Showing results (2571-2580 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 19, 2022
Taurine enhances the antitumor efficacy of PD-1 antibody by boosting CD8+ T cell functionYu Ping, Jiqi Shan, Yaqing Liu, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1986
Localization of human sarcoma with radiolabeled monoclonal antibody. A preliminary studyJ A Greager, J M Brown, D G Pavel, et al.Cancer Immunology, Immunotherapy : CII|June 18, 2025
Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinomaSiyou Deng, Qi Wang, Yueping Li, et al.Cancer Immunology, Immunotherapy : CII|July 23, 2025
A multifunctional T-cell engager containing CD80 enhances prostate cancer treatmentDisen Nie, Yao Jiang, Hui Li, et al.Cancer Immunology, Immunotherapy : CII|July 12, 2025
Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomasJing Ma, Tina Sarén, Chuan Jin, et al.Cancer Immunology, Immunotherapy : CII|July 12, 2025
Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancerGuo Ji, Hanlin Sun, Simo Chen, et al.Cancer Immunology, Immunotherapy : CII|May 31, 2025
Cancer therapy via neoepitope-specific monoclonal antibody cocktailsColin J Hartman, Asmaa O Mohamed, Girja S Shukla, et al.Cancer Immunology, Immunotherapy : CII|June 18, 2025
Extracellular vesicles derived from mature dendritic cells loaded with cDC1-specific chemokine XCL1 combined with chemotherapy-induced ICD for the treatment of castration-resistant prostate cancerZhongqiang Fan, Zhao Wang, Hui Zhang, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2025
Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1Barry D Hock, Liping Goddard, Lachlan J Dobson, et al.Cancer Immunology, Immunotherapy : CII|October 10, 2025
The single-cell atlas of colorectal cancer reveals cellular heterogeneity and key molecular features of the tumor immune microenvironmentJunHu Li, ZhiQiang Liu, BoYu Zhang, et al.Pageof 652